| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1339928-25-4 | Fimepinostat(CUDC907) |
≥98% | | 询价 |
| 2 | 1245537-68-1 | BGT226(NVP-BGT226) |
≥98% | | 询价 |
| 3 | 900515-16-4 | AS-252424 |
≥98% | | 询价 |
| 4 | 677297-51-7 | TG100-115 |
≥98% | | 询价 |
| 5 | 941685-37-6 | S-Ruxolitinib(INCB-018424) |
≥98% | | 询价 |
| 6 | 69-57-8 | Penicillin G Sodium |
| 500mg | 询价 |
| 7 | 28718-90-3 | DAPI solution |
| 1mg/mL *1mL | 询价 |
| 8 | 958852-01-2 | GSK1059615 |
≥98% | | 询价 |
| 9 | 1032754-93-0 | Apitolisib(GDC-0980,RG7422) |
≥98% | | 询价 |
| 10 | 1173900-33-8 | AZD-6482(KIN-193) |
≥98% | | 询价 |
| 11 | 1013101-36-4 | PF-04691502 |
≥98% | | 询价 |
| 12 | 677338-12-4 | PIK-90 |
≥98% | | 询价 |
| 13 | 1086062-66-9 | Omipalisib(GSK2126458,GSK458) |
≥98% | | 询价 |
| 14 | 593960-11-3 | PIK-93 |
≥98% | | 询价 |
| 15 | 329-98-6 | PMSF |
| 100mg, 200mg | 询价 |
| 16 | 152121-47-6 | Adezmapimod(SB203580) |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 17 | 3810-74-0 | Streptomycin sulfate |
| 500mg | 询价 |
| 18 | 1173097-76-1 | U0126-EtOH |
| 5mg, 10mg, 25mg, 50mg, 100mg | 询价 |
| 19 | 53123-88-9 | Rapamycin |
| 5mg, 10mg, 25mg, 50mg | 询价 |
| 20 | 1349796-36-6 | Voxtalisib Analog(SAR245409 Analog,XL765 Analog) |
≥98% | | 询价 |
| 21 | 1166227-08-2 | A66 |
≥98% | | 询价 |
| 22 | 18883-66-4 | Streptozotocin |
| 100mg, 200mg, 500mg | 询价 |
| 23 | 7365-45-9 | HEPES |
| | 询价 |
| 24 | | 磷酸酶抑制剂Cocktail(不含EDTA) |
| | 询价 |
| 25 | 5142-23-4 | 3-Methyladenine(3-MA) |
≥98% | | 询价 |
| 26 | 1032350-13-2 | MK-2206 2HCl |
| 2mg, 5mg, 10mg, 50mg | 询价 |
| 27 | | 蛋白酶抑制剂Cocktail(不含EDTA,100X DMSO储液) |
| | 询价 |
| 28 | 372196-77-5 | PIK-75 HCl |
≥98% | | 询价 |
| 29 | 648450-29-7 | AS-605240 |
≥98% | | 询价 |
| 30 | 475110-96-4 | ZSTK474 |
≥98% | | 询价 |
| 31 | 956958-53-5 | Pilaralisib analog(XL147 analog,SAR245408 analog) |
≥98% | | 询价 |
| 32 | 19545-26-7 | Wortmannin(SL-2052 KY-12420) |
≥98% | | 询价 |
| 33 | 371242-69-2 | IC-87114 |
≥98% | | 询价 |
| 34 | 663619-89-4 | TGX-221 |
≥98% | | 询价 |
| 35 | 503468-95-9 | NU7441(KU57788) |
≥98% | | 询价 |
| 36 | 371935-74-9 | PI-103 |
≥98% | | 询价 |
| 37 | 934493-76-2 | Voxtalisib(XL-765,SAR-245409) |
≥98% | | 询价 |
| 38 | 1005264-47-0 | MX69 |
≥98% | | 询价 |
| 39 | 5291-32-7 | Eprenetapopt(APR246 PRIMA-1MET) |
≥98% | | 询价 |
| 40 | 198904-31-3 | Atazanavir |
≥98% | | 询价 |
| 41 | 781661-94-7 | YM155(Sepantronium Bromide) |
≥98% | | 询价 |
| 42 | 1675203-84-5 | BMS-202 |
≥98% | | 询价 |
| 43 | 511296-88-1 | Pifithrin-βHBr(QB102 Cyclic Pifithrin-α) |
≥98% | | 询价 |
| 44 | 60477-34-1 | Pifithrin-β(QB-102 and Cyclic-Pifithrin-α) |
≥98% | | 询价 |
| 45 | 1019206-88-2 | Regorafenib monohydrate(BAY73-4506) |
≥98% | | 询价 |
| 46 | 835621-07-3 | Regorafenib HCl(BAY-73-4506) |
≥98% | | 询价 |
| 47 | 905586-69-8 | AZ 960 |
≥98% | | 询价 |
| 48 | 1337531-36-8 | GSK2606414 |
≥98% | | 询价 |
| 49 | 405060-95-9 | Salubrinal |
≥98% | | 询价 |
| 50 | 61825-94-3 | Oxaliplatin(Eloxatin L-OHP JM-83 RP-54780 SR-96669) |
≥98% | | 询价 |
| 51 | 1005342-46-0 | LCL161 |
≥98% | | 询价 |
| 52 | 1001600-56-1 | BV-6 |
≥98% | | 询价 |
| 53 | 550-24-3 | Embelin |
≥98% | | 询价 |
| 54 | 1071992-99-8 | AT406(Xevinapant,SM406,ARRY334543) |
≥98% | | 询价 |
| 55 | 873652-48-3 | GDC-0152(RG7419) |
≥98% | | 询价 |
| 56 | 1260251-31-7 | Birinapant(TL32711) |
≥98% | | 询价 |
| 57 | 936091-14-4 | TG101209 |
≥98% | | 询价 |
| 58 | 1201438-56-3 | Duvelisib(IPI-145,INK1197) |
≥98% | | 询价 |
| 59 | 1597403-47-8 | ISRIB(trans-isomer) |
≥98% | | 询价 |
| 60 | 939981-39-2 | RG-7112(RO-5045337) |
≥98% | | 询价 |
m.cnreagent.com